CHO Plus, Inc. ( a leading developer of biopharmaceutical manufacturing technology, announces that U.S. Patent No. 12,270,055 ...

Apr. 11, 2025 — A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments.

Stem cells are cells that have the capacity to self-renew by dividing and to develop into more mature, specialised cells. Stem cells can be unipotent, multipotent, pluripotent or totipotent ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Apr. 9, 2025 — A new study has found that certain bacteria living in the nose may influence how likely someone is to get a COVID-19 infection. The research reveals ...

Secondary antibodies used: goat anti-rabbit IgG conjugated to Alexa Fluor 488 (1:1000, Cell Signaling Technology), goat anti-mouse IgG conjugated to Alex Fluor 647 (1:1000, Cell Signaling Technology).